Sourced material
One topic per file, generated on a plan and a cadence, superseded rather than overwritten. This is what the domain dossiers are synthesized from.
A research report is the sourced material a domain
dossier is synthesized from — generated on a plan and a cadence, one topic per file.
A report carries no confidence tags. Its bracketed markers say who might have
an incentive to shade a line; none of them says anyone checked it. To reach a score, a line has
to be drafted onto a candidate as unverified and pass the Verifier or the
Corroborator, like everything else.
Care pathway, site of service, and what is already in the room — canine equine distal limb wounds
Condition, prevalence, incidence and trend direction — canine equine distal limb wounds
US pet insurance penetration among owned dogs
Major US veterinary distributor catalogs and canister-free NPWT — what is listed today
Reference products and why people stop using them — canine equine distal limb wounds
What changed in ten years and what is newly possible or cheap — canine equine distal limb wounds
Condition, prevalence, incidence and trend direction — chronic subjective tinnitus neuromodulation
Entrants, exits, funding, launches, recalls — chronic subjective tinnitus neuromodulation
Reference products and why people stop using them — chronic subjective tinnitus neuromodulation
FDA's stated and exercised post-market enforcement posture toward animal-only devices
Veterinary NPWT device cost-of-goods and distributor margin stack at a $180-$320 practice price
Care pathway, site of service, and what is already in the room — ctdna mrd assay validation
Guideline position, pivotal evidence, effect sizes, negative findings — ctDNA MRD assay validation
Condition, prevalence, incidence and trend direction — ctdna mrd assay validation
Absolute MRD test volumes from Natera and Guardant SEC filings (10-K/10-Q), 2023-2026
Entrants, exits, funding, launches, recalls — ctdna mrd assay validation
Enumeration of US laboratories offering or developing tumor-informed ctDNA MRD tests
Reference products and why people stop using them — ctDNA MRD assay validation
Codes, payment rates, coverage policy, and whose budget it comes from — ctdna mrd assay validation
What changed in ten years and what is newly possible or cheap — ctdna mrd assay validation
Condition, prevalence, incidence and trend direction — feline ckd subcutaneous fluid therapy
Reference products and why people stop using them — feline ckd subcutaneous fluid therapy
Condition, prevalence, incidence and trend direction — internal hemorrhoids office based treatment
Entrants, exits, funding, launches, recalls — internal hemorrhoids office based treatment
Reference products and why people stop using them — internal hemorrhoids office based treatment
Condition, prevalence, incidence and trend direction — lower extremity lymphedema
Entrants, exits, funding, launches, recalls — lower extremity lymphedema compression therapy
Reference products and why people stop using them — lower extremity lymphedema compression therapy
Condition, prevalence, incidence and trend direction — neonatal hyperbilirubinemia home phototherapy
Entrants, exits, funding, launches, recalls — neonatal hyperbilirubinemia home phototherapy
Reference products and why people stop using them — neonatal hyperbilirubinemia home phototherapy
Condition, prevalence, incidence and trend direction — pediatric obstructive sleep apnea testing
Entrants, exits, funding, launches, recalls — pediatric obstructive sleep apnea testing
Reference products and why people stop using them — pediatric obstructive sleep apnea testing
Condition, prevalence, incidence and trend direction — pediatric persistent asthma home monitoring
Entrants, exits, funding, launches, recalls — pediatric persistent asthma home monitoring
Reference products and why people stop using them — pediatric persistent asthma home monitoring
Care pathway, site of service, and what is already in the room — potassium monitoring ckd
Guideline position, pivotal evidence, effect sizes, negative findings — potassium monitoring ckd
Codes, payment rates, coverage policy, and whose budget it comes from — potassium monitoring ckd
What changed in ten years and what is newly possible or cheap — potassium monitoring in CKD
Prescriber, operator, purchaser, payer and patient — separate incentives — potassium monitoring ckd
Care pathway, site of service, and what is already in the room — stress urinary incontinence
Guideline position, pivotal evidence, effect sizes, negative findings — stress urinary incontinence
Condition, prevalence, incidence and trend direction — stress urinary incontinence
Entrants, exits, funding, launches, recalls — stress urinary incontinence
Reference products and why people stop using them — stress urinary incontinence
Codes, payment rates, coverage policy, and whose budget it comes from — stress urinary incontinence
What changed in ten years and what is newly possible or cheap — stress urinary incontinence
Condition, prevalence, incidence and trend direction — veterinary diabetes glucose monitoring
Reference products and why people stop using them — veterinary diabetes glucose monitoring